Interactive Investor
>>

Lee's Pharmaceutical Holdings Ltd (SEHK:950) Share Price

950

Lee's Pharmaceutical Holdings Ltd

APAC company

Right Arrow 1

Healthcare

Right Arrow 2

Drug Manufacturers - Specialty & Generic

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XHKG

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT+8, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Lee's Pharmaceutical Holdings Ltd is a Cayman Island-based research-driven and market-oriented biopharmaceutical company. It is integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales, and marketing in China with global perspectives. It focuses on cardiovascular and infectious diseases, dermatology, oncology, gynecology, ophthalmology, and others. Its portfolio has two categories of Proprietary products and Licensed-in products. Its maximum revenue is generated from China. The Proprietary Products portfolio includes Livaracine, Yallaferon, Eyprotor. And its License-in Products include Carnitene, Ferplex, ALOXI, Zanidip, Dafnegin, Veloderm, Levocarnitine Oral Solution, Remodulin.Lee's Pharmaceutical Holdings Ltd through its subsidiaries, develops, manufactures and markets pharmaceutical products. It is engaged in areas such as cardiovascular, dermatology, oncology, gynecology and ophthalmology.

SEHK:950

KYG5438W1116

HKD

Loading...

Loading Comparison

Latest 950 News